IL197701A0 - Micellar nanoparticles of chemical substances - Google Patents
Micellar nanoparticles of chemical substancesInfo
- Publication number
- IL197701A0 IL197701A0 IL197701A IL19770109A IL197701A0 IL 197701 A0 IL197701 A0 IL 197701A0 IL 197701 A IL197701 A IL 197701A IL 19770109 A IL19770109 A IL 19770109A IL 197701 A0 IL197701 A0 IL 197701A0
- Authority
- IL
- Israel
- Prior art keywords
- chemical substances
- micellar nanoparticles
- micellar
- nanoparticles
- substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85302306P | 2006-10-20 | 2006-10-20 | |
| EP06122648 | 2006-10-20 | ||
| PCT/EP2007/061194 WO2008046905A1 (en) | 2006-10-20 | 2007-10-19 | Micellar nanoparticles of chemical substances |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL197701A0 true IL197701A0 (en) | 2009-12-24 |
| IL197701A IL197701A (en) | 2014-12-31 |
Family
ID=38661928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL197701A IL197701A (en) | 2006-10-20 | 2009-03-19 | Solid composition comprising nanosized micelles and a process for preparing them |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2083799A1 (en) |
| JP (1) | JP5439182B2 (en) |
| KR (1) | KR101434334B1 (en) |
| AU (1) | AU2007312233B2 (en) |
| CA (1) | CA2666587C (en) |
| EA (1) | EA026213B1 (en) |
| IL (1) | IL197701A (en) |
| NO (1) | NO20091975L (en) |
| WO (1) | WO2008046905A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR071375A1 (en) | 2008-04-22 | 2010-06-16 | Solvay Pharm Gmbh | FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY, PREPARATION AND PRODUCT PROCESS |
| RU2519193C2 (en) | 2008-09-12 | 2014-06-10 | Критикал Фармасьютикалс Лимитед | Improving absorption of therapeutic agents through mucous membranes or skin |
| AR075180A1 (en) * | 2009-01-29 | 2011-03-16 | Novartis Ag | SOLID ORAL FORMULATIONS OF A PYRIDOID-PYRIMIDINONE |
| US20150111246A1 (en) * | 2012-04-24 | 2015-04-23 | Astrazeneca Pharmaceuticals Lp | Site-specific enzymatic modification of exendins and analogs thereof |
| GB201304662D0 (en) | 2013-03-14 | 2013-05-01 | Sigmoid Pharma Ltd | Compositions |
| FR3014317B1 (en) * | 2013-12-11 | 2016-04-22 | Patrice Binay | NOVEL PROCESS FOR THE PRODUCTION OF TRANSMUCAL PHARMACEUTICAL FORMULATIONS AND FORMATIONS THUS OBTAINED |
| EP3424493A1 (en) * | 2017-07-07 | 2019-01-09 | SolMic Research GmbH | Stable cannabinoid compositions |
| EP3886910A4 (en) * | 2018-11-30 | 2022-07-27 | Canopy Growth Corporation | Compositions comprising a cannabinoid or a cannabis-derived compound, methods of making and use |
| EP4005561A4 (en) * | 2019-07-25 | 2022-12-07 | Beijing Shenogen Pharma Group Ltd. | Nano-micelle preparation of icaritin and preparation method therefor and application thereof |
| CN112915121A (en) | 2019-12-06 | 2021-06-08 | 汉义生物科技（北京）有限公司 | Cannabinoid nano micelle preparation and preparation method thereof |
| CA3160750A1 (en) | 2019-12-09 | 2021-06-17 | Anthony Richard Gerardi | Oral product comprising a cannabinoid |
| AU2022315590A1 (en) * | 2021-07-22 | 2024-01-18 | Nicoventures Trading Limited | Composition comprising a constituent, derivative or extract of cannabis |
| CA3224601A1 (en) * | 2021-07-22 | 2023-01-26 | Steven Alderman | Constituent, derivative or extract of cannabis in a water soluble matrix |
| IL310125A (en) * | 2021-07-22 | 2024-03-01 | Nicoventures Trading Ltd | Compositions comprising a constituent, derivative or extract of cannabis |
| WO2023002201A1 (en) * | 2021-07-22 | 2023-01-26 | Nicoventures Trading Limited | Compositions comprising constituents, derivatives or extracts of cannabis |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5281420A (en) * | 1992-05-19 | 1994-01-25 | The Procter & Gamble Company | Solid dispersion compositions of tebufelone |
| US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| FR2804604B1 (en) * | 2000-02-09 | 2005-05-27 | Sanofi Synthelabo | USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF USEFUL DRUGS TO FACILITATE THE STOPPAGE OF TOBACCO CONSUMPTION |
| CN1529595A (en) * | 2001-09-21 | 2004-09-15 | ������ҩ������˾ | 4,5-hydro-1H-pyrazole derivative having protent CB1-antagonistic |
| RU2299199C2 (en) * | 2001-09-21 | 2007-05-20 | Солвей Фармасьютикалс Б.В. | Novel derivatives of 4,5-dihydro-1h-pyrazole showing cb1-antagonistic activity |
| GB0305941D0 (en) * | 2003-03-14 | 2003-04-23 | Camurus Ab | Composition |
| US20050096365A1 (en) * | 2003-11-03 | 2005-05-05 | David Fikstad | Pharmaceutical compositions with synchronized solubilizer release |
| JP4994039B2 (en) * | 2003-11-26 | 2012-08-08 | スパーナス ファーマシューティカルズ インコーポレイテッド | Micellar system useful for delivery of lipophilic or hydrophobic compounds |
| US7498309B2 (en) * | 2003-11-29 | 2009-03-03 | Sangstat Medical Corporation | Pharmaceutical compositions for bioactive peptide agents |
| US20050169992A1 (en) * | 2003-12-23 | 2005-08-04 | Frank Jao | Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| TW200529890A (en) * | 2004-02-10 | 2005-09-16 | Takeda Pharmaceutical | Sustained-release preparations |
| WO2006045799A2 (en) * | 2004-10-25 | 2006-05-04 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| US20060280790A1 (en) * | 2005-04-08 | 2006-12-14 | Ju Tzuchi R | Pharmaceutical formulations |
| AU2006236497A1 (en) * | 2005-04-18 | 2006-10-26 | Rubicon Research Pvt. Ltd. | Bioenhanced compositions |
-
2007
- 2007-10-19 KR KR1020097010351A patent/KR101434334B1/en active IP Right Grant
- 2007-10-19 AU AU2007312233A patent/AU2007312233B2/en not_active Ceased
- 2007-10-19 WO PCT/EP2007/061194 patent/WO2008046905A1/en active Application Filing
- 2007-10-19 CA CA2666587A patent/CA2666587C/en not_active Expired - Fee Related
- 2007-10-19 EA EA200900572A patent/EA026213B1/en not_active IP Right Cessation
- 2007-10-19 EP EP07821558A patent/EP2083799A1/en not_active Withdrawn
- 2007-10-19 JP JP2009532815A patent/JP5439182B2/en not_active Expired - Fee Related
-
2009
- 2009-03-19 IL IL197701A patent/IL197701A/en active IP Right Grant
- 2009-05-20 NO NO20091975A patent/NO20091975L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2666587A1 (en) | 2008-04-24 |
| AU2007312233B2 (en) | 2012-09-20 |
| WO2008046905A1 (en) | 2008-04-24 |
| KR101434334B1 (en) | 2014-08-28 |
| EP2083799A1 (en) | 2009-08-05 |
| JP2010506886A (en) | 2010-03-04 |
| KR20090077074A (en) | 2009-07-14 |
| AU2007312233A1 (en) | 2008-04-24 |
| EA026213B1 (en) | 2017-03-31 |
| IL197701A (en) | 2014-12-31 |
| NO20091975L (en) | 2009-07-09 |
| EA200900572A1 (en) | 2009-10-30 |
| JP5439182B2 (en) | 2014-03-12 |
| CA2666587C (en) | 2015-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL197701A0 (en) | Micellar nanoparticles of chemical substances | |
| EP1984376A4 (en) | Chemical compounds | |
| EP2059480A4 (en) | Methods of forming nanoparticles | |
| EP2057987A4 (en) | Pharmaceutical composition containing statin-encapsulated nanoparticle | |
| GB0713117D0 (en) | Chemical compounds | |
| EP2081603A4 (en) | Fluorescent chemical sensor | |
| GB0611507D0 (en) | Chemical compounds | |
| EP2320910A4 (en) | Chemical compounds and uses | |
| GB0611506D0 (en) | Chemical compounds | |
| PL1816116T6 (en) | Chemical compositions and methods of making them | |
| GB0623388D0 (en) | Chemical compounds | |
| EP2349266A4 (en) | Sulfonamide containing compounds and uses thereof | |
| GB0611552D0 (en) | Chemical compounds | |
| GB0611458D0 (en) | Assessment of functional status | |
| HK1199829A1 (en) | Micellar nanoparticles of chemical substances | |
| GB0625198D0 (en) | Chemical compounds | |
| GB0601215D0 (en) | Chemical compounds | |
| GB0613284D0 (en) | Detection of substances | |
| GB0623357D0 (en) | Chemical compounds | |
| GB0615670D0 (en) | Chemical compounds | |
| GB0614552D0 (en) | Chemical Compounds | |
| PL2124880T3 (en) | Fluorescent nanoparticles | |
| GB0625371D0 (en) | Chemical compounds | |
| GB0619677D0 (en) | Destruction of chemical substances | |
| GB0624145D0 (en) | Chemical substance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |